Eupraxia Pharmaceuticals Hosts Analyst Day on EP-104GI for Eosinophilic Esophagitis
Bitget2026/10/22 12:30- Eupraxia Pharmaceuticals will host a virtual analyst day on EP-104GI for eosinophilic esophagitis on November 13, 2026, at 8:30 a.m. ET.
- Management will join the Craig Hallum Biotech Catalyst Virtual Conference on October 22, 2026; fireside chat starts at 10:30 a.m. ET.
- BIO-Europe participation is scheduled for November 9-11, 2026, in Cologne, Germany, with one-on-one meetings.
- The Stifel 2026 Healthcare Conference runs November 10-12 in New York; management’s fireside chat is November 10 at 4:40 p.m. ET.
- A presentation at the Jefferies Global Healthcare Conference in London, November 16-19, 2026, is scheduled for November 16 at 1:30 p.m. GMT.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Report: ECB officials tend to favor a rate hike in December, with inflation outlook being the key variable
According to media reports, officials from the European Central Bank generally believe that, based on current data and the economic impact of the Middle East war, if the inflation situation does not improve, the European Central Bank will raise interest rates by 25 basis points in December. Currently, the market is pricing an 85% probability of a 25 basis point rate hike by the ECB in December. Analysts note that although the ECB has left room for another rate increase in December, the Governing Council is laying the groundwork to end the current tightening cycle.
BUZZ - DaVita raises the lower end of its 2026 profit forecast, shares fall
Crypto prices
More
